Quick Answer
Guggul is a resin-derived herbal supplement sometimes promoted for blood sugar, cholesterol, inflammation, and weight. It has not been proven to improve A1C or treat diabetes. Most diabetes findings come from cells or animals, while the limited human research cannot show that guggul itself was responsible for any glucose change.
Human cholesterol results are mixed. In one well-designed trial, guggulipid did not lower cholesterol and LDL cholesterol increased compared with placebo. Guggul can also cause stomach symptoms or an allergic rash and may interact with medicines.
Do not replace insulin, diabetes tablets, statins, or other prescribed treatment with guggul. Ask your doctor or pharmacist to check the exact product against your medication list before using it.
I first became curious about guggul after seeing the extract in Asian herbal shops. The right question is not whether a traditional product is “European” or “Asian,” but whether a specific preparation has been tested in people, whether the outcome matters clinically, and whether it is safe with the medicines a patient already uses.
What Is Guggul?
Guggul, also spelled guggulu or guggal, is the aromatic oleo-gum resin collected from Commiphora wightii, a name often used interchangeably in older literature with Commiphora mukul. It has a long history in Ayurvedic practice.
These terms do not guarantee equivalent products. Extract strength, ingredients, manufacturing, and guggulsterone content can vary. Results from one preparation should not automatically be applied to every resin, capsule, powder, or multi-herb formula.
Can Guggul Lower Blood Sugar?
There is not enough reliable human evidence to recommend guggul for blood sugar control. Laboratory studies and diabetic-rat experiments have reported changes in glucose-related enzymes, insulin resistance, or inflammatory markers. These experiments can help researchers form hypotheses, but they do not prove that a supplement is effective or safe for a person with diabetes.
A randomized trial in women with type 2 diabetes tested a capsule containing three ingredients: Terminalia chebula, Commiphora mukul, and Commiphora myrrha. Fasting glucose improved, but A1C did not change significantly. Because all three herbs were given together, the study cannot tell us whether guggul alone had any effect.
| Claim | What has been studied | Practical conclusion |
|---|---|---|
| Lower blood glucose | Mainly cell and animal experiments; one human trial used a three-herb combination. | Not proven for guggul alone. |
| Lower A1C | No convincing trial evidence for guggul alone. A1C did not improve significantly in the combination trial. | Not established. |
| Improve cholesterol | Human trials have produced conflicting findings; stronger placebo-controlled trials found no benefit. | Mixed and unreliable. |
| Support weight loss | Insufficient controlled human evidence for guggul alone. | Not established. |
| Reduce inflammation or complications | Mostly laboratory and animal research. | Experimental, not clinical treatment. |
Current American Diabetes Association guidance does not recommend herbs or spices for glycemic benefit because evidence is insufficient. For a broader discussion, see my guide to herbs and blood sugar.
Does Guggul Lower Cholesterol?
Guggul became popular partly because early studies and laboratory mechanisms suggested a cholesterol-lowering effect. Later controlled trials did not confirm a dependable benefit.
- In a randomized, placebo-controlled trial of 103 adults with high cholesterol, LDL cholesterol increased by about 4%–5% in the guggulipid groups while it decreased by 5% with placebo. Six guggulipid participants developed a hypersensitivity rash.
- In a separate randomized trial of 90 people, a guggulu-and-Triphala combination was no better than placebo for total or LDL cholesterol. Two participants receiving the herbal combination developed a rash.
Some reviews that combine older trials suggest possible lipid improvement, but formulations, study quality, populations, and methods vary. This uncertainty is not evidence that guggul works only in one ethnic group or because one population eats “greasier” food. Those explanations are not established.
Possible Side Effects
Short trials do not tell us everything about long-term safety. Reported or plausible problems include:
Digestive symptoms
Nausea, diarrhea, stomach discomfort, belching, or an unpleasant taste may occur.
Skin reactions
Itching or a hypersensitivity rash occurred in controlled human trials. Stop the product and seek advice if a rash develops.
Headache or dizziness
These nonspecific symptoms may occur and should not be ignored if severe, persistent, or accompanied by glucose changes.
Guggul Medication Interactions
Interaction information is incomplete, which is one reason a pharmacist should review the exact product. Important concerns include:
| Medicine or condition | Why caution is needed | What to do |
|---|---|---|
| Diabetes medicines and insulin | Guggul is not proven to lower glucose, but experimental glucose effects and multi-ingredient products make the response unpredictable. | Do not combine without clinician review. Monitor as your diabetes team advises. |
| Propranolol | A small human pharmacokinetic study found that guggulipid reduced propranolol exposure, which could reduce its effect. | Ask a pharmacist or prescriber before use. |
| Diltiazem | The same small study found reduced diltiazem exposure. | Avoid self-combining; your clinician may advise against it. |
| Thyroid medicine or thyroid disease | Animal studies suggest guggul constituents may stimulate thyroid activity. Human relevance and safe dosing are unclear. | Do not use without review from the clinician managing your thyroid. |
| Statins and other lipid medicines | Guggul has not shown reliable cholesterol benefit, and interaction data for many lipid medicines are incomplete. | Do not replace or add to treatment without approval. |
| Blood thinners, antiplatelet drugs, or surgery | Bleeding-interaction evidence is uncertain, but theoretical concerns and incomplete product data justify caution. | Tell the prescribing clinician and surgical team about all supplements. |
Bring the bottle: A brand name is not enough. Show your pharmacist the Supplement Facts panel, exact dose, other ingredients, lot number, and how often you take it. Multi-herb products can have additional interactions.
Who Should Avoid Guggul or Seek Specialist Advice?
Avoid starting guggul without personal medical advice if you:
- are pregnant, trying to conceive, or breastfeeding;
- are a child or teenager;
- have a thyroid disorder or use thyroid medication;
- have liver disease, kidney disease, a bleeding disorder, or a hormone-sensitive condition;
- have surgery or a procedure planned;
- take insulin, diabetes tablets, heart or blood-pressure medicines, blood thinners, antiplatelet medicines, or cholesterol treatment;
- have previously reacted to guggul, myrrh-like resins, or another ingredient in the product.
There is no evidence-based guggul dose for diabetes. I therefore do not recommend a dose for lowering glucose or A1C.
If You Are Already Taking Guggul
- Do not stop prescribed treatment. Continue insulin, diabetes tablets, statins, thyroid medicine, and heart treatment unless your prescriber changes them.
- Record the exact product. Write down the brand, ingredients, standardized extract information, dose, start date, and reason you take it.
- Ask for an interaction review. Contact your doctor or pharmacist, especially if you take propranolol, diltiazem, thyroid medicine, a blood thinner, or several diabetes or heart medicines.
- Watch for patterns. If you monitor glucose, follow your usual plan and record unexpected highs, lows, rash, stomach symptoms, or changes in heart rate or blood pressure.
- Stop and seek advice for a suspected reaction. Use urgent care for breathing difficulty, facial swelling, severe rash, fainting, chest pain, jaundice, or a serious glucose problem.
Doctor’s Note
When a cell experiment or diabetic-rat study looks promising, it is a reason for better human research—not a reason to treat patients immediately. For guggul, the gap between biological plausibility and reliable clinical benefit remains large. I would prioritize proven glucose and cardiovascular care while reviewing any supplement for interactions and product quality.
Frequently Asked Questions
Is guggul proven to lower blood sugar?
No. Most positive findings come from cell or animal studies. A human diabetes trial used guggul with two other herbs and did not show a significant A1C improvement, so it cannot prove that guggul alone works.
Can guggul replace metformin or insulin?
No. Guggul has not been shown to replace any diabetes medicine. Stopping prescribed treatment can cause dangerous hyperglycemia, ketones, or other complications.
Does guggul lower LDL cholesterol?
Results are mixed. In a strong placebo-controlled trial, LDL increased in the guggulipid groups. Do not replace prescribed cholesterol treatment with guggul.
Can I take guggul with propranolol or diltiazem?
Do not combine them without prescriber or pharmacist approval. A small human study found that guggulipid reduced exposure to both medicines, which could make them less effective.
Is guggul safe if I have a thyroid condition?
Safety is uncertain. Animal research suggests possible thyroid stimulation, so people with hypothyroidism, hyperthyroidism, thyroid nodules, or thyroid medication need specialist review before use.
How much guggul should a person with diabetes take?
There is no established effective or safe diabetes dose. Product strengths also vary. Do not use a dose from an animal study, advertisement, or another person’s regimen.
References
- American Diabetes Association Professional Practice Committee. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2026.
- Shokoohi R, et al. Effects of an Herbal Combination on Glycemic Control and Lipid Profile in Diabetic Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. 2017.
- Sharma B, et al. Effects of guggulsterone isolated from Commiphora mukul in high-fat-diet-induced diabetic rats. 2009.
- Szapary PO, et al. Guggulipid for the Treatment of Hypercholesterolemia: A Randomized Controlled Trial. JAMA. 2003.
- Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial. 2020.
- Dalvi SS, et al. Effect of gugulipid on bioavailability of diltiazem and propranolol. Journal of the Association of Physicians of India. 1994.
- Panda S, Kar A. Guggulu potentially ameliorates hypothyroidism in female mice. Phytotherapy Research. 2005.
- U.S. Food and Drug Administration. FDA 101: Dietary Supplements.
Medical disclaimer: This page provides general education and does not diagnose, treat, or replace personalized advice. Do not start, stop, or change a supplement, insulin, diabetes medicine, thyroid medicine, heart or blood-pressure medicine, blood thinner, or cholesterol treatment without guidance from your healthcare professional.